Noxafil and Cefuroxime drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Noxafil (posaconazole) and Cefuroxime (cefuroxime sodium). Common drug interactions include neutrophil count decreased among females and asthma among males.

The phase IV clinical study analyzes what interactions people have when they take Noxafil and Cefuroxime. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Noxafil?

Noxafil has active ingredients of posaconazole. eHealthMe is studying from 5,919 Noxafil users. Check the latest studies of Noxafil.

What is Cefuroxime?

Cefuroxime has active ingredients of cefuroxime sodium. It is often used in sinusitis. eHealthMe is studying from 12,999 Cefuroxime users. Check the latest studies of Cefuroxime.

On Jul, 09, 2026

12 people who take Noxafil and Cefuroxime together, and have interactions are studied.

Noxafil and Cefuroxime drug interactions.

What are the common drug interactions of Noxafil and Cefuroxime, by gender? *:

female:

Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Anaemia (lack of blood)
Decreased appetite
Diarrhoea
Fatigue (feeling of tiredness)
Haematoma (collection of blood outside the blood vessels)
Hypokalaemia (low potassium)
Lymphatic disorder (disease of lymphatic system)
Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
Platelet count decreased

male:

Asthma
Infection
Polyserositis (general inflammation of serous membranes, with effusion)
Diarrhoea
Lung infection
Lung transplant
Neutropenia (an abnormally low number of neutrophils)
Pneumonia bacterial (pneumonia associated with bacterial infection)

What are the common drug interactions of Noxafil and Cefuroxime, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Acute graft versus host disease in intestine (acute complication in intestine following an allogeneic tissue/blood transplant)

50-59:

Diarrhoea
Lung transplant
Neutropenia (an abnormally low number of neutrophils)
Pneumonia bacterial (pneumonia associated with bacterial infection)

60+:

Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
Platelet count decreased
Vaginal haemorrhage (vaginal bleeding)
Vomiting
Infection
Polyserositis (general inflammation of serous membranes, with effusion)
Anaemia (lack of blood)
Diarrhoea

What are the existing conditions these people have? *

Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 16.67%
Multiple Myeloma (cancer of the plasma cells): 2 people, 16.67%
Restrictive Pulmonary Disease (reduction in total lung capacity): 1 person, 8.33%
Respiratory Disorder (respiratory disease): 1 person, 8.33%
Prostate Cancer: 1 person, 8.33%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 8.33%
Neoplasm Malignant (cancer tumour): 1 person, 8.33%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 8.33%
Asthma: 1 person, 8.33%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Noxafil and Cefuroxime?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously